280 related articles for article (PubMed ID: 10848722)
1. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.
Farmer RD; Lawrenson RA; Todd JC; Williams TJ; MacRae KD; Tyrer F; Leydon GM
Br J Clin Pharmacol; 2000 Jun; 49(6):580-90. PubMed ID: 10848722
[TBL] [Abstract][Full Text] [Related]
2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
3. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database.
Todd J; Lawrenson R; Farmer RD; Williams TJ; Leydon GM
Hum Reprod; 1999 Jun; 14(6):1500-5. PubMed ID: 10357966
[TBL] [Abstract][Full Text] [Related]
5. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus database.
Farmer RD; Lawrenson RA; Todd JC; Williams TJ; MacRae K
Hum Reprod Update; 1999; 5(6):688-706. PubMed ID: 10652979
[TBL] [Abstract][Full Text] [Related]
7. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
Farmer RD; Todd JC; Lewis MA; MacRae KD; Williams TJ
Contraception; 1998 Feb; 57(2):67-70. PubMed ID: 9589831
[TBL] [Abstract][Full Text] [Related]
8. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Dinger J; Assmann A; Möhner S; Minh TD
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
Farmer RD; Lawrenson RA
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
[TBL] [Abstract][Full Text] [Related]
10. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Spitzer WO; Lewis MA; Heinemann LA; Thorogood M; MacRae KD
BMJ; 1996 Jan; 312(7023):83-8. PubMed ID: 8555935
[TBL] [Abstract][Full Text] [Related]
11. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet; 1995 Dec; 346(8990):1582-8. PubMed ID: 7500749
[TBL] [Abstract][Full Text] [Related]
12. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database.
Farmer RD; Williams TJ; Simpson EL; Nightingale AL
BMJ; 2000 Aug 19-26; 321(7259):477-9. PubMed ID: 10948026
[TBL] [Abstract][Full Text] [Related]
13. Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data.
Schink T; Princk C; Braitmaier M; Haug U
BJOG; 2022 Dec; 129(13):2107-2116. PubMed ID: 35876787
[TBL] [Abstract][Full Text] [Related]
14. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
Samuelsson E; Hägg S
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):674-81. PubMed ID: 15225194
[TBL] [Abstract][Full Text] [Related]
15. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2015 May; 350():h2135. PubMed ID: 26013557
[TBL] [Abstract][Full Text] [Related]
16. Absolute and attributable risk of venous thromboembolism in women on combined cyproterone acetate and ethinylestradiol.
Lidegaard Ø
J Obstet Gynaecol Can; 2003 Jul; 25(7):575-7. PubMed ID: 12851669
[TBL] [Abstract][Full Text] [Related]
17. The risk of venous thromboembolism in users of postcoital contraceptive pills.
Vasilakis C; Jick SS; Jick H
Contraception; 1999 Feb; 59(2):79-83. PubMed ID: 10361621
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?
Lawrenson R; Farmer R
Contraception; 2000 Aug; 62(2 Suppl):21S-28S; discussion 37S-38S. PubMed ID: 11102599
[TBL] [Abstract][Full Text] [Related]
19. Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill.
Black C; Kaye JA; Jick H
Br J Clin Pharmacol; 2002 Jun; 53(6):637-40. PubMed ID: 12047488
[TBL] [Abstract][Full Text] [Related]
20. Fatal venous thromboembolism associated with different combined oral contraceptives: a study of incidences and potential biases in spontaneous reporting.
Hedenmalm K; Samuelsson E
Drug Saf; 2005; 28(10):907-16. PubMed ID: 16180940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
